PSNL vs. AVAH, VRDN, TDOC, OMDA, AHCO, GRAL, FTRE, PNTG, CDNA, and CSTL
Should you be buying Personalis stock or one of its competitors? The main competitors of Personalis include Aveanna Healthcare (AVAH), Viridian Therapeutics (VRDN), Teladoc Health (TDOC), Omada Health (OMDA), AdaptHealth (AHCO), GRAIL (GRAL), Fortrea (FTRE), The Pennant Group (PNTG), CareDx (CDNA), and Castle Biosciences (CSTL). These companies are all part of the "healthcare" industry.
Personalis vs. Its Competitors
Personalis (NASDAQ:PSNL) and Aveanna Healthcare (NASDAQ:AVAH) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, analyst recommendations, risk, profitability, dividends, valuation, institutional ownership and earnings.
Personalis has a beta of 1.76, indicating that its stock price is 76% more volatile than the S&P 500. Comparatively, Aveanna Healthcare has a beta of 2.04, indicating that its stock price is 104% more volatile than the S&P 500.
Personalis presently has a consensus target price of $7.42, suggesting a potential upside of 45.71%. Aveanna Healthcare has a consensus target price of $7.50, suggesting a potential downside of 7.18%. Given Personalis' stronger consensus rating and higher possible upside, equities research analysts plainly believe Personalis is more favorable than Aveanna Healthcare.
In the previous week, Personalis and Personalis both had 3 articles in the media. Aveanna Healthcare's average media sentiment score of 1.10 beat Personalis' score of -0.01 indicating that Aveanna Healthcare is being referred to more favorably in the news media.
Aveanna Healthcare has higher revenue and earnings than Personalis. Personalis is trading at a lower price-to-earnings ratio than Aveanna Healthcare, indicating that it is currently the more affordable of the two stocks.
61.9% of Personalis shares are owned by institutional investors. Comparatively, 88.0% of Aveanna Healthcare shares are owned by institutional investors. 3.8% of Personalis shares are owned by insiders. Comparatively, 7.8% of Aveanna Healthcare shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
Aveanna Healthcare has a net margin of 0.85% compared to Personalis' net margin of -113.70%. Personalis' return on equity of -47.57% beat Aveanna Healthcare's return on equity.
Summary
Aveanna Healthcare beats Personalis on 10 of the 15 factors compared between the two stocks.
Get Personalis News Delivered to You Automatically
Sign up to receive the latest news and ratings for PSNL and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding PSNL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Personalis Competitors List
Related Companies and Tools
This page (NASDAQ:PSNL) was last updated on 9/5/2025 by MarketBeat.com Staff
